Reviva Pharmaceuticals Holdings, Inc. (RVPH)
0.5324
-0.01
(-1.12%)
USD |
OTCM |
Sep 09, 16:00
Reviva Pharmaceuticals Holdings Total Liabilities (Quarterly) : 5.933M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.933M |
| March 31, 2026 | 6.119M |
| December 31, 2025 | 7.276M |
| September 30, 2025 | 9.783M |
| June 30, 2025 | 12.09M |
| March 31, 2025 | 11.54M |
| December 31, 2024 | 14.69M |
| September 30, 2024 | 17.61M |
| June 30, 2024 | 14.09M |
| March 31, 2024 | 14.84M |
| December 31, 2023 | 17.98M |
| September 30, 2023 | 13.91M |
| June 30, 2023 | 10.22M |
| March 31, 2023 | 7.117M |
| December 31, 2022 | 6.607M |
| September 30, 2022 | 3.681M |
| June 30, 2022 | 4.583M |
| Date | Value |
|---|---|
| March 31, 2022 | 3.907M |
| December 31, 2021 | 2.718M |
| September 30, 2021 | 1.625M |
| June 30, 2021 | 2.014M |
| March 31, 2021 | 2.142M |
| February 28, 2021 | |
| November 30, 2020 | |
| August 31, 2020 | |
| May 31, 2020 | |
| February 29, 2020 | 3.263M |
| November 30, 2019 | 2.314M |
| August 31, 2019 | 2.248M |
| May 31, 2019 | 2.241M |
| February 28, 2019 | 2.237M |
| November 30, 2018 | 2.236M |
| August 31, 2018 | 2.215M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Jaguar Health, Inc. | 29.27M |
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
| Johnson & Johnson | 116.09B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 21.14M |
| Shareholders Equity (Quarterly) | 15.21M |
| Debt to Equity Ratio | 0.0095 |
| Current Ratio | 3.563 |
| Net Debt Paydown Yield | 0.19% |